Irinotecan hydrochloride is a pharmaceutical raw material used in the manufacture of anticancer medications. It is a salt form of irinotecan, a compound that acts through inhibition of topoisomerase I.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Irinotecan hydrochloride?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Irinotecan hydrochloride trihydrate
pharmaceutical raw material
Irinotecan
pharmaceutical raw material
Milrinone lactate
pharmaceutical raw material
Ferrous succinate
pharmaceutical raw material
Sodium picosulfate
pharmaceutical raw material
Cobicistat
pharmaceutical raw material
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride
GURKHSYORGJETM-WAQYZQTGSA-N
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl
Sourcing Irinotecan hydrochloride?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.